Jefferies Group’s Core Laboratories CLB Stock Holding History

Jefferies Group’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-9,000	Closed	-$1.52M	–	1952
2013 Q3	$1.52M	Buy	+9,000	New	+$1.4M	0.01%	722

Other funds holding CLB

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Jefferies Group's CLB Position: Q1 2019 in Review

Jefferies Group sold out of Core Laboratories (CLB) in Q1 2019, closing a stake of 13,642 shares — an estimated $814K sold.

Jefferies Group first reported a position in CLB in Q3 2013 and held it in 7 quarters. The position peaked at $814K in Q4 2018. 313 funds tracked by Wall St. Rank hold CLB as of Q1 2019.

Jefferies Group reported no remaining Core Laboratories position as of Q1 2019 after selling out during the quarter.
Jefferies Group sold 13,642 Core Laboratories shares in Q1 2019, an estimated $814K.
Jefferies Group first reported a position in Core Laboratories in Q3 2013 and held it in 7 quarters.
Jefferies Group's Core Laboratories position peaked at $814K in Q4 2018.
313 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2019.

Based on Jefferies Group's 13F filing for Q1 2019, filed 15 May 2019.